Cellular Therapy View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2020-04-02

AUTHORS

Nirav N. Shah , Adam Levin , Vivek Radhakrishnan , Parameswaran Hari

ABSTRACT

Cell-based immune therapies have been a mainstay for the management of patients with hematological malignancies. While historically allogeneic transplant and donor lymphocyte infusions were the predominant form of cell therapy utilized, recent developments in T cell-based treatments have significantly advanced the field. Specifically, the advent of CD19-targeted chimeric antigen receptor-modified T (CAR-T) cell therapies has provided a new powerful tool for patients with relapsed and refractory B cell malignancies. In this chapter, the development of CAR-T cell therapies will be reviewed along with its current and future applications and a detailed description of the potential toxicities associated with this novel treatment. In conclusion, CAR-T cells have revolutionized the field of hematological malignancies and high potential to alter the natural history of these diseases. More... »

PAGES

1-21

Book

TITLE

Contemporary Bone Marrow Transplantation

ISBN

978-3-319-64938-2
978-3-319-64938-2

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-3-319-64938-2_3-1

DOI

http://dx.doi.org/10.1007/978-3-319-64938-2_3-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1128848931


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA", 
          "id": "http://www.grid.ac/institutes/grid.30760.32", 
          "name": [
            "Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shah", 
        "givenName": "Nirav N.", 
        "id": "sg:person.015270014615.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015270014615.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA", 
          "id": "http://www.grid.ac/institutes/grid.30760.32", 
          "name": [
            "Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Levin", 
        "givenName": "Adam", 
        "id": "sg:person.014766516573.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014766516573.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tata Medical Center, Kolkata, India", 
          "id": "http://www.grid.ac/institutes/grid.430884.3", 
          "name": [
            "Tata Medical Center, Kolkata, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Radhakrishnan", 
        "givenName": "Vivek", 
        "id": "sg:person.015100736543.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015100736543.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA", 
          "id": "http://www.grid.ac/institutes/grid.30760.32", 
          "name": [
            "Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hari", 
        "givenName": "Parameswaran", 
        "id": "sg:person.01170403141.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01170403141.13"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2020-04-02", 
    "datePublishedReg": "2020-04-02", 
    "description": "Cell-based immune therapies have been a mainstay for the management of patients with hematological malignancies. While historically allogeneic transplant and donor lymphocyte infusions were the predominant form of cell therapy utilized, recent developments in T cell-based treatments have significantly advanced the field. Specifically, the advent of CD19-targeted chimeric antigen receptor-modified T (CAR-T) cell therapies has provided a new powerful tool for patients with relapsed and refractory B cell malignancies. In this chapter, the development of CAR-T cell therapies will be reviewed along with its current and future applications and a detailed description of the potential toxicities associated with this novel treatment. In conclusion, CAR-T cells have revolutionized the field of hematological malignancies and high potential to alter the natural history of these diseases.", 
    "editor": [
      {
        "familyName": "Chandy", 
        "givenName": "Mammen", 
        "type": "Person"
      }, 
      {
        "familyName": "Radhakrishnan", 
        "givenName": "Vivek S", 
        "type": "Person"
      }, 
      {
        "familyName": "Sukumaran", 
        "givenName": "Reghu", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-3-319-64938-2_3-1", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-3-319-64938-2", 
        "978-3-319-64938-2"
      ], 
      "name": "Contemporary Bone Marrow Transplantation", 
      "type": "Book"
    }, 
    "keywords": [
      "cell therapy", 
      "hematological malignancies", 
      "chimeric antigen receptor-modified T-cell therapy", 
      "cell-based immune therapy", 
      "T cell-based treatments", 
      "refractory B-cell malignancies", 
      "CAR T-cell therapy", 
      "donor lymphocyte infusion", 
      "management of patients", 
      "T-cell therapy", 
      "CAR T cells", 
      "B-cell malignancies", 
      "cell-based treatments", 
      "lymphocyte infusion", 
      "allogeneic transplants", 
      "immune therapy", 
      "cell malignancies", 
      "novel treatments", 
      "therapy", 
      "natural history", 
      "cellular therapy", 
      "malignancy", 
      "patients", 
      "treatment", 
      "potential toxicity", 
      "CD19", 
      "transplant", 
      "predominant form", 
      "infusion", 
      "mainstay", 
      "disease", 
      "toxicity", 
      "conclusion", 
      "cells", 
      "management", 
      "development", 
      "history", 
      "new powerful tool", 
      "advent", 
      "potential", 
      "recent developments", 
      "detailed description", 
      "powerful tool", 
      "tool", 
      "high potential", 
      "future applications", 
      "form", 
      "chapter", 
      "description", 
      "field", 
      "applications"
    ], 
    "name": "Cellular Therapy", 
    "pagination": "1-21", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1128848931"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-3-319-64938-2_3-1"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-3-319-64938-2_3-1", 
      "https://app.dimensions.ai/details/publication/pub.1128848931"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-12-01T06:48", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/chapter/chapter_195.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-3-319-64938-2_3-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-64938-2_3-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-64938-2_3-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-64938-2_3-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-64938-2_3-1'


 

This table displays all metadata directly associated to this object as RDF triples.

143 TRIPLES      22 PREDICATES      74 URIs      67 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-3-319-64938-2_3-1 schema:about anzsrc-for:11
2 anzsrc-for:1107
3 schema:author Ncdb2e749f6fb4a0dad94dd3802e3dfc9
4 schema:datePublished 2020-04-02
5 schema:datePublishedReg 2020-04-02
6 schema:description Cell-based immune therapies have been a mainstay for the management of patients with hematological malignancies. While historically allogeneic transplant and donor lymphocyte infusions were the predominant form of cell therapy utilized, recent developments in T cell-based treatments have significantly advanced the field. Specifically, the advent of CD19-targeted chimeric antigen receptor-modified T (CAR-T) cell therapies has provided a new powerful tool for patients with relapsed and refractory B cell malignancies. In this chapter, the development of CAR-T cell therapies will be reviewed along with its current and future applications and a detailed description of the potential toxicities associated with this novel treatment. In conclusion, CAR-T cells have revolutionized the field of hematological malignancies and high potential to alter the natural history of these diseases.
7 schema:editor N905b3bd4901d49b9993a0c6a551c772e
8 schema:genre chapter
9 schema:isAccessibleForFree false
10 schema:isPartOf N5d7c8f1a9d7f4ba0901125987840a072
11 schema:keywords B-cell malignancies
12 CAR T cells
13 CAR T-cell therapy
14 CD19
15 T cell-based treatments
16 T-cell therapy
17 advent
18 allogeneic transplants
19 applications
20 cell malignancies
21 cell therapy
22 cell-based immune therapy
23 cell-based treatments
24 cells
25 cellular therapy
26 chapter
27 chimeric antigen receptor-modified T-cell therapy
28 conclusion
29 description
30 detailed description
31 development
32 disease
33 donor lymphocyte infusion
34 field
35 form
36 future applications
37 hematological malignancies
38 high potential
39 history
40 immune therapy
41 infusion
42 lymphocyte infusion
43 mainstay
44 malignancy
45 management
46 management of patients
47 natural history
48 new powerful tool
49 novel treatments
50 patients
51 potential
52 potential toxicity
53 powerful tool
54 predominant form
55 recent developments
56 refractory B-cell malignancies
57 therapy
58 tool
59 toxicity
60 transplant
61 treatment
62 schema:name Cellular Therapy
63 schema:pagination 1-21
64 schema:productId Nc5133b3e79a844399ddf395422520378
65 Ncff4127907d04781b6ee803e9699c159
66 schema:publisher Nc15edce33103423ab84dbbb02b0e00e6
67 schema:sameAs https://app.dimensions.ai/details/publication/pub.1128848931
68 https://doi.org/10.1007/978-3-319-64938-2_3-1
69 schema:sdDatePublished 2022-12-01T06:48
70 schema:sdLicense https://scigraph.springernature.com/explorer/license/
71 schema:sdPublisher Naf13a56b1d7e4871878440d81fd7be37
72 schema:url https://doi.org/10.1007/978-3-319-64938-2_3-1
73 sgo:license sg:explorer/license/
74 sgo:sdDataset chapters
75 rdf:type schema:Chapter
76 N4f18410abf1a4d4ab6c20b8234378e12 schema:familyName Sukumaran
77 schema:givenName Reghu
78 rdf:type schema:Person
79 N5d7c8f1a9d7f4ba0901125987840a072 schema:isbn 978-3-319-64938-2
80 schema:name Contemporary Bone Marrow Transplantation
81 rdf:type schema:Book
82 N7b9990a77add4836b09992611d369829 rdf:first N4f18410abf1a4d4ab6c20b8234378e12
83 rdf:rest rdf:nil
84 N8659718e964f45ef9c72275a2903bb9a schema:familyName Chandy
85 schema:givenName Mammen
86 rdf:type schema:Person
87 N88e66df01f86445395e51d45aea7a36f rdf:first sg:person.01170403141.13
88 rdf:rest rdf:nil
89 N89a99b9209da48c99009cbda53d18542 rdf:first N8db4e3127f1d46c8a926e30f7e1098c2
90 rdf:rest N7b9990a77add4836b09992611d369829
91 N8db4e3127f1d46c8a926e30f7e1098c2 schema:familyName Radhakrishnan
92 schema:givenName Vivek S
93 rdf:type schema:Person
94 N905b3bd4901d49b9993a0c6a551c772e rdf:first N8659718e964f45ef9c72275a2903bb9a
95 rdf:rest N89a99b9209da48c99009cbda53d18542
96 Na2a1c3ceace74bc0920763e4c886d7c6 rdf:first sg:person.015100736543.25
97 rdf:rest N88e66df01f86445395e51d45aea7a36f
98 Naf13a56b1d7e4871878440d81fd7be37 schema:name Springer Nature - SN SciGraph project
99 rdf:type schema:Organization
100 Nc15edce33103423ab84dbbb02b0e00e6 schema:name Springer Nature
101 rdf:type schema:Organisation
102 Nc5133b3e79a844399ddf395422520378 schema:name doi
103 schema:value 10.1007/978-3-319-64938-2_3-1
104 rdf:type schema:PropertyValue
105 Ncdb2e749f6fb4a0dad94dd3802e3dfc9 rdf:first sg:person.015270014615.39
106 rdf:rest Nde7e33ebffa540f2a6ca45ec2d73e342
107 Ncff4127907d04781b6ee803e9699c159 schema:name dimensions_id
108 schema:value pub.1128848931
109 rdf:type schema:PropertyValue
110 Nde7e33ebffa540f2a6ca45ec2d73e342 rdf:first sg:person.014766516573.70
111 rdf:rest Na2a1c3ceace74bc0920763e4c886d7c6
112 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
113 schema:name Medical and Health Sciences
114 rdf:type schema:DefinedTerm
115 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
116 schema:name Immunology
117 rdf:type schema:DefinedTerm
118 sg:person.01170403141.13 schema:affiliation grid-institutes:grid.30760.32
119 schema:familyName Hari
120 schema:givenName Parameswaran
121 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01170403141.13
122 rdf:type schema:Person
123 sg:person.014766516573.70 schema:affiliation grid-institutes:grid.30760.32
124 schema:familyName Levin
125 schema:givenName Adam
126 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014766516573.70
127 rdf:type schema:Person
128 sg:person.015100736543.25 schema:affiliation grid-institutes:grid.430884.3
129 schema:familyName Radhakrishnan
130 schema:givenName Vivek
131 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015100736543.25
132 rdf:type schema:Person
133 sg:person.015270014615.39 schema:affiliation grid-institutes:grid.30760.32
134 schema:familyName Shah
135 schema:givenName Nirav N.
136 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015270014615.39
137 rdf:type schema:Person
138 grid-institutes:grid.30760.32 schema:alternateName Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA
139 schema:name Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA
140 rdf:type schema:Organization
141 grid-institutes:grid.430884.3 schema:alternateName Tata Medical Center, Kolkata, India
142 schema:name Tata Medical Center, Kolkata, India
143 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...